The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study.
about
Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation TherapyMultidrug Resistance Proteins (MRPs) and Cancer TherapyATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 10 (ABCC10) are not primary resistance factors for cabazitaxel.IKK inhibition increases bortezomib effectiveness in ovarian cancer.Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer.Thiazole-valine peptidomimetic (TTT-28) antagonizes multidrug resistance in vitro and in vivo by selectively inhibiting the efflux activity of ABCB1.Revisiting the role of nanoparticles as modulators of drug resistance and metabolism in cancer.Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells.Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters.Tea nanoparticle, a safe and biocompatible nanocarrier, greatly potentiates the anticancer activity of doxorubicin.GSK1904529A, a Potent IGF-IR Inhibitor, Reverses MRP1-Mediated Multidrug Resistance.Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study.
P2860
Q26775004-455E52C1-36AD-44F4-B1FE-8E16262B779CQ26992204-AC994354-263E-4DFD-AA53-4BC3D3689B8AQ36121125-62756214-65C6-4AF6-828B-D79DC93D7B39Q36413454-C02E23D6-C658-4AC2-BFA8-44EFCF6EB087Q37362640-90E9FB78-BD8D-4960-892C-EECD0A31F4D6Q37633542-DAF14AD5-24B5-43D3-81E2-B638D8624525Q38707907-2B66FE39-B73F-4FE5-8426-96ECC87C4362Q38744729-0BD1F09C-2D11-4BE0-94F0-FA2FEE8E74EBQ41168634-A62EC7A9-D453-4DA6-9C41-20E8A81DE4ADQ42052611-403E3F64-FA7A-418E-A3B0-39B7E44D18B4Q48156853-CC3AA731-4C50-4830-A3AC-27E8D7349640Q50673610-BF4FF13D-0EB2-4785-8F2B-B113E2B4A7D0
P2860
The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The small molecule tyrosine ki ...... cal and pharmacokinetic study.
@ast
The small molecule tyrosine ki ...... cal and pharmacokinetic study.
@en
type
label
The small molecule tyrosine ki ...... cal and pharmacokinetic study.
@ast
The small molecule tyrosine ki ...... cal and pharmacokinetic study.
@en
prefLabel
The small molecule tyrosine ki ...... cal and pharmacokinetic study.
@ast
The small molecule tyrosine ki ...... cal and pharmacokinetic study.
@en
P2093
P2860
P356
P1433
P1476
The small molecule tyrosine ki ...... cal and pharmacokinetic study.
@en
P2093
Amal Kaddoumi
Atish Patel
Charles R Ashby
Kamlesh Sodani
Nagaraju Anreddy
Rishil J Kathawala
Saeed Alqahtani
Yi-Jun Wang
P2860
P304
P356
10.18632/ONCOTARGET.2638
P407
P577
2015-01-01T00:00:00Z